Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What's Holding up FDA's Electronic Drug Labeling Rule?
Regulatory Focus
Wednesday, February 12, 2014 - 12:02pm
tags:
FDA, electronic labeling
Biotechs pocket another $115M as the IPO boom thunders on
Fierce Biotech
Wednesday, February 12, 2014 - 11:59am
tags:
biotech, IPOs, Flexion, Eagle Pharmaceuticals
Galena Biopharma Pays For Stock-Touting Campaign While Insiders Cash Out Millions
TheStreet.com
Wednesday, February 12, 2014 - 10:13am
tags:
Galena Biopharma
Dara BioSciences raises $6M in a registered direct offering
Yahoo/Fly on the Wall
Wednesday, February 12, 2014 - 10:10am
tags:
DARA Biosciences, stock offering
StemCells finishes enrolling first of two patient cohorts in HuCNS-SC study
Yahoo/Fly on the Wall
Wednesday, February 12, 2014 - 10:09am
tags:
StemCells, clinical trials, HuCNS-SC, dry age-related macular degeneration
Amgen Inc's Deep Pipeline Offsets Some of the Price Risk
Motley Fool
Wednesday, February 12, 2014 - 10:07am
tags:
Amgen, earnings, evolocumab
Reckitt Benckiser says pharma review ongoing
Yahoo/Reuters
Wednesday, February 12, 2014 - 10:05am
tags:
Reckitt Benckiser
Actelion’s Lung Drug May Face Study Against Gilead Rival
Bloomberg
Wednesday, February 12, 2014 - 9:50am
tags:
Actelion, Gilead Sciences, Opsumit, Letairis, PAH, pulmonary arterial hypertension
Prediction: Chelsea Wins Northera FDA Approval Friday
TheStreet.com
Wednesday, February 12, 2014 - 9:48am
tags:
Chelsea Therapeutics, Northera, FDA
3 Ways Ariad Pharmaceuticals Can Salvage Iclusig
Motley Fool
Wednesday, February 12, 2014 - 9:19am
tags:
Ariad Pharmaceuticals, Iclusig, acute lymphoblastic leukemia
GlaxoSmithKline plc Vs AstraZeneca plc — Which Is The Better Bet For Income And Growth?
Motley Fool
Wednesday, February 12, 2014 - 9:19am
tags:
GSK, AstraZeneca, China
Ventrus Phase 3 trial of Diltiazem showed no significant difference to placebo
Yahoo/Fly on the Wall
Wednesday, February 12, 2014 - 9:17am
tags:
Ventrus Biosciences, Diltiazem, VEN 307
Antidepressant R&D Takes Another Hit with J&J
Motley Fool
Wednesday, February 12, 2014 - 9:15am
tags:
R&D, JNJ, antidepressants, Addex, ADX71149
Frantic Pace In Cancer Immunotherapy: Merck Vs. Bristol-Myers
Seeking Alpha
Wednesday, February 12, 2014 - 9:14am
tags:
cancer immunotherapy, Merck, Bristol-Myers Squibb, Amgen, Incyte, Pfizer, MK-3475, Ablynx, Yervoy
Ligand Beats Q4 Earnings
Yahoo/Zacks.com
Wednesday, February 12, 2014 - 9:12am
tags:
Ligand Pharmaceuticals, earnings
Narrower-than-Expected Loss at Seattle Genetics
Yahoo/Zacks.com
Wednesday, February 12, 2014 - 9:11am
tags:
Seattle Genetics, earnings
Gilead’s Milligan Says Hepatitis C Drug Attracts Payers
Bloomberg
Wednesday, February 12, 2014 - 9:11am
tags:
Gilead Sciences, hepatitus C, Sovaldi, insurance
Indian Regulators to Shadow U.S. FDA on Plant Inspections
Bloomberg
Wednesday, February 12, 2014 - 9:09am
tags:
India, inspections, FDA, drug manufacturing
GlaxoSmithKline R&D chief touts the future of 'electroceuticals'
Fierce Biotech
Tuesday, February 11, 2014 - 4:50pm
tags:
GSK, R&D, electroceuticals
3 Major Health-Care Deals You Need to Know About
Motley Fool
Tuesday, February 11, 2014 - 4:48pm
tags:
Forest Labs, Aptalis, Bristol-Myers Squibb, AstraZeneca, JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.